Elmer Bancorp, Inc. Announces Cash Dividend and Annual Meeting Date
ELMER, N.J.–(BUSINESS WIRE)–ELMER BANCORP, INC. (“Elmer Bancorp” or the “Company”) (OTC Pink: ELMA), parent company of The First National Bank... Read more.
Kontrol Technologies Announces New Intended Normal Course Issuer Bid Through Cboe Canada
TORONTO–(BUSINESS WIRE)–$KNR #esg—Kontrol Technologies Corp. (Cboe CA:KNR) (OTCQB:KNRLF) (FSE:1K8) ( “Kontrol” or the “Company”) announces... Read more.
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Luna Innovations Incorporated Investors – LUNA
NEW YORK–(BUSINESS WIRE)–Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of... Read more.
Allego to Postpone Fourth Quarter and Full Year 2023 Financial Results Conference Call
ARNHEM, Netherlands–(BUSINESS WIRE)–Allego N.V. (“Allego” or the “Company”) (NYSE: ALLG), a leading pan-European public electric vehicle fast... Read more.
Allego to Postpone Fourth Quarter and Full Year 2023 Financial Results Conference Call
ARNHEM, Netherlands–(BUSINESS WIRE)–Allego N.V. (“Allego” or the “Company”) (NYSE: ALLG), a leading pan-European public electric vehicle fast... Read more.
Verisign to Report First Quarter 2024 Financial Results
RESTON, Va.–(BUSINESS WIRE)–VeriSign, Inc. (NASDAQ: VRSN), a global provider of critical internet infrastructure and domain name registry services, today... Read more.
Atlassian Announces Dates for Third Quarter of Fiscal Year 2024 Financial Results and Investor Day
Team Anywhere/SAN FRANCISCO–(BUSINESS WIRE)–Atlassian Corporation (NASDAQ: TEAM), a leading provider of team collaboration and productivity software,... Read more.
E*TRADE from Morgan Stanley Releases Monthly Sector Rotation Study
NEW YORK–(BUSINESS WIRE)–E*TRADE from Morgan Stanley today released the data from its monthly sector rotation study, based on the E*TRADE customer notional... Read more.
Omeros Corporation Reports Fourth Quarter and Year-End 2023 Financial Results
– Conference Call Today at 4:30 p.m. ET SEATTLE–(BUSINESS WIRE)–Omeros Corporation (Nasdaq: OMER), a clinical-stage biopharmaceutical company committed... Read more.
Acorda Cancels Q4 and Year End 2023 Earnings Conference Call Scheduled for April 1, 2024
PEARL RIVER, N.Y.–(BUSINESS WIRE)–Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it will no longer hold its fourth quarter and year end... Read more.